Stochastic appearance of mammary tumors in transgenic mice carrying the MMTV/c-neu oncogene - PubMed (original) (raw)
Stochastic appearance of mammary tumors in transgenic mice carrying the MMTV/c-neu oncogene
L Bouchard et al. Cell. 1989.
Abstract
Transgenic mice carrying the activated c-neu oncogene under the control of the mouse mammary tumor virus (MMTV) long terminal repeat were produced. Epithelial hyperplasia of epididymis, seminal vesicles, and salivary glands, and dysplasia of harderian glands, were induced. Moreover, in females of our four lines, independent but multiple mammary tumors arose asynchronously, between 5 and 10 months of age, as stochastic events. Histologically, poorly differentiated adenocarcinomas, with intratumor necrosis and calcifications, arose adjacent to morphologically normal epithelium. High transgene expression was detected in all mammary tumors tested and in normal mammary glands before the appearance of the tumors. Together these results suggest that the expression of the activated c-neu oncogene was necessary but not sufficient to induce malignant transformation of the mammary epithelial cells. These tumors appear to be an adequate model for human breast cancers overexpressing c-neu.
Similar articles
- Single-step induction of mammary adenocarcinoma in transgenic mice bearing the activated c-neu oncogene.
Muller WJ, Sinn E, Pattengale PK, Wallace R, Leder P. Muller WJ, et al. Cell. 1988 Jul 1;54(1):105-15. doi: 10.1016/0092-8674(88)90184-5. Cell. 1988. PMID: 2898299 - Early and multifocal tumors in breast, salivary, harderian and epididymal tissues developed in MMTY-Neu transgenic mice.
Lucchini F, Sacco MG, Hu N, Villa A, Brown J, Cesano L, Mangiarini L, Rindi G, Kindl S, Sessa F, et al. Lucchini F, et al. Cancer Lett. 1992 Jul 10;64(3):203-9. doi: 10.1016/0304-3835(92)90044-v. Cancer Lett. 1992. PMID: 1322235 - Activated neu induces rapid tumor progression.
Guy CT, Cardiff RD, Muller WJ. Guy CT, et al. J Biol Chem. 1996 Mar 29;271(13):7673-8. doi: 10.1074/jbc.271.13.7673. J Biol Chem. 1996. PMID: 8631805 - Use of mouse mammary tumour virus (MMTV)/neu transgenic mice to identify genes collaborating with the c-erbB-2 oncogene in mammary tumour development.
Jolicoeur P, Bouchard L, Guimond A, Ste-Marie M, Hanna Z, Dievart A. Jolicoeur P, et al. Biochem Soc Symp. 1998;63:159-65. Biochem Soc Symp. 1998. PMID: 9513720 Review. - The C3(1)/SV40 T-antigen transgenic mouse model of mammary cancer: ductal epithelial cell targeting with multistage progression to carcinoma.
Green JE, Shibata MA, Yoshidome K, Liu ML, Jorcyk C, Anver MR, Wigginton J, Wiltrout R, Shibata E, Kaczmarczyk S, Wang W, Liu ZY, Calvo A, Couldrey C. Green JE, et al. Oncogene. 2000 Feb 21;19(8):1020-7. doi: 10.1038/sj.onc.1203280. Oncogene. 2000. PMID: 10713685 Review.
Cited by
- Male reproductive phenotypes of genetically altered laboratory mice (Mus musculus): a review based on pertinent literature from the last three decades.
Buranaamnuay K. Buranaamnuay K. Front Vet Sci. 2024 Mar 4;11:1272757. doi: 10.3389/fvets.2024.1272757. eCollection 2024. Front Vet Sci. 2024. PMID: 38500604 Free PMC article. Review. - Veterinary Management of Harderian Gland Tumors in Cancer Rainbow (crainbow) HER2-Positive Mice.
Garner A, Ginzel JD, Snyder JC, Everitt JI, Landon CD. Garner A, et al. Comp Med. 2022 Dec 1;72(6):403-409. doi: 10.30802/AALAS-CM-22-000061. Comp Med. 2022. PMID: 36744508 Free PMC article. - Reproductive history determines Erbb2 locus amplification, WNT signalling and tumour phenotype in a murine breast cancer model.
Ordonez LD, Melchor L, Greenow KR, Kendrick H, Tornillo G, Bradford J, Giles P, Smalley MJ. Ordonez LD, et al. Dis Model Mech. 2021 May 1;14(5):dmm048736. doi: 10.1242/dmm.048736. Epub 2021 May 18. Dis Model Mech. 2021. PMID: 34003256 Free PMC article. - Prevention of mammary carcinogenesis in MMTV-neu mice by targeting RLIP.
Singhal J, Kulkarni P, Horne D, Awasthi S, Salgia R, Singhal SS. Singhal J, et al. Mol Carcinog. 2021 Mar;60(3):213-223. doi: 10.1002/mc.23285. Epub 2021 Feb 5. Mol Carcinog. 2021. PMID: 33544936 Free PMC article. - Icaritin reduces prostate cancer progression via inhibiting high-fat diet-induced serum adipokine in TRAMP mice model.
Wu X, Long X, Yang C, Chen H, Sharkey C, Rashid K, Hu M, Liu Y, Huang Q, Chen Q, Hu J, Jiang H. Wu X, et al. J Cancer. 2020 Sep 21;11(22):6556-6564. doi: 10.7150/jca.48413. eCollection 2020. J Cancer. 2020. PMID: 33046976 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials
Miscellaneous